-
Apr.222024NEWS
HanAll Biopharma awards 2024 National Industry Awards for Research and Development Excellence
HanAll Biopharma awards 2024 National Industry Awards for Research and Development Excellence
-
Mar.212024NEWS
HanAll Biopharma Reports Full-Year 2023 Financial Results and Provides Business Update
HanAll Biopharma Reports Full-Year 2023 Financial Results and Provides Business Update
-
Mar.182024NEWS
HanAll Biopharma Opens Applications for 2024 Pharmaceutical Industry Fellowship Program Targeting Indonesian Physicians
HanAll Biopharma Opens Applications for 2024 Pharmaceutical Industry Fellowship Program Targeting In..
-
Dec.112023NEWS
HanAll Biopharma’s Partner, NurrOn Pharmaceuticals Incorporated Appoints Dr. Almira Chabi, MD, EGMP to Board of Directors
HanAll Biopharma’s Partner, NurrOn Pharmaceuticals Incorporated Appoints Dr. Almira Chabi, MD, EGMP ..
-
Oct.262023NEWS
HanAll Biopharma Reports Third Quarter 2023 Financial Results and Provides a Business Update
HanAll Biopharma Reports Third Quarter 2023 Financial Results and Provides a Business Update
-
Oct.112023NEWS
HanAll Biopharma, Daewoong Pharmaceutical and NurrOn Pharmaceuticals Initiate First-in-Human Phase 1 Clinical Study of HL192
HanAll Biopharma, Daewoong Pharmaceutical and NurrOn Pharmaceuticals Initiate First-in-Human Phase 1..